Latest Macular edema Stories
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
TARRYTOWN, N.Y., Nov. 18, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that Bayer HealthCare's Japanese subsidiary, Bayer Yakuhin, Ltd.
ATLANTA, Nov. 17, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
New research from Kantar Health’s National Health and Wellness Survey shows European patients with macular edema are more likely to use insulin and have been diagnosed longer. New
TARRYTOWN, N.Y., Oct. 17, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.
Findings help product development at Diopsys, Inc. Pine Brook, NJ (PRWEB) October 10, 2014 Research scientists from the University of Alabama, Birmingham
CEO to Discuss Milestone FDA Approval of ILUVIEN as the First Long-Term Treatment for Diabetic Macular Edema ATLANTA, Oct. 9, 2014 /PRNewswire/ -- Alimera Sciences, Inc.
New study shows that the Diopsys NOVA-ERG acts as window to the brain Pine Brook, NJ (PRWEB) October 09, 2014 Research scientists from the University
-- Fourth indication for injection treatment that can stabilize and improve vision(1) -- mCNV a leading cause of visual impairment among those 20-50 years of age(9) Since
- To play, gamble.
- To impose upon; delude; trick; humbug; also, to joke; chaff.
- A deceitful game or trick; trickery; humbug; nonsense.